As a result, the strong performance of creatinine and cystatin C partly reflects their incorporation into these equations, and our findings should be interpreted as an evaluation of marker performance within the CKD-EPI framework rather than an independent validation against measured GFR. This evidence concerns the gene CST3 and chronic kidney disease.